UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Periodontal therapeutics: Current host‐modulation agents and future directions

Periodontology 2000, 2020-02, Vol.82 (1), p.186-204

2020

Volltextzugriff (PDF)

Dose‐response assessment of chemically modified curcumin in experimental periodontitis

Journal of periodontology (1970), 2019-05, Vol.90 (5), p.535-545

2019

Volltextzugriff (PDF)

Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins

Current medicinal chemistry, 2012-09, Vol.19 (25), p.4348-4358

2012

Volltextzugriff (PDF)

pKa, zinc- and serum albumin-binding of curcumin and two novel biologically-active chemically-modified curcumins

Current medicinal chemistry, 2012-09, Vol.19 (25), p.4367-4375

2012

Volltextzugriff (PDF)

Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation

Annals of medicine (Helsinki), 2006-01, Vol.38 (5), p.306-321

2006

Volltextzugriff (PDF)

Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases

International dental journal, 2016-06, Vol.66 (3), p.127-135

2016

Volltextzugriff (PDF)

A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations

Mediators of Inflammation, 2014-01, Vol.2014 (9), p.1-10

2014

Volltextzugriff (PDF)

Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24

PloS one, 2013-09, Vol.8 (9), p.e69884

2013

Volltextzugriff (PDF)

Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation

Pharmacological research, 2011-12, Vol.64 (6), p.573-579

2011

Volltextzugriff (PDF)

The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial

The Journal of the American Dental Association (1939), 2011-03, Vol.142 (3), p.262

2011

Volltextzugriff (PDF)

A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

Journal of Diabetes Research, 2016-01, Vol.2016 (2016), p.1-11

2016

Volltextzugriff (PDF)

4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation

Mediators of Inflammation, 2013-01, Vol.2013 (2013), p.1-10

2013

Volltextzugriff (PDF)

Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non‐antimicrobial tetracycline analog (COL‐3) in a metastatic prostate cancer model

International journal of cancer, 2002-03, Vol.98 (2), p.297-309

2002

Volltextzugriff (PDF)

Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study

Acta odontologica Scandinavica, 2008-01, Vol.66 (4), p.219-224

2008

Volltextzugriff (PDF)

Introduction and background

Pharmacological research, 2011-02, Vol.63 (2), p.99-101

Golub, Lorne M

2011

Volltextzugriff (PDF)

Inhibition of Matrix Metalloproteinase‐Mediated Periodontal Bone Loss in Rats: A Comparison of 6 Chemically Modified Tetracyclines

Journal of periodontology (1970), 2002-07, Vol.73 (7), p.726-734

2002

Volltextzugriff (PDF)

Using tetracyclines to treat osteoporotic/osteopenic bone loss: From the basic science laboratory to the clinic

Pharmacological research, 2011-02, Vol.63 (2), p.121-129

2011

Volltextzugriff (PDF)

Periodontal disease in acute coronary syndrome patients

American journal of dentistry, 2021-04, Vol.34 (2), p.97

2021

Volltextzugriff (PDF)

Metalloproteinase Inhibitors, Nonantimicrobial Chemically Modified Tetracyclines, and Ilomastat Block Bacillus anthracis Lethal Factor Activity in Viable Cells

Infection and Immunity, 2005-11, Vol.73 (11), p.7548-7557

2005

Volltextzugriff (PDF)

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis

Inflammation, 2017-08, Vol.40 (4), p.1436-1449

2017

Volltextzugriff (PDF)

DIFFERENTIAL SUSCEPTIBILITY OF HUMAN SP-B GENETIC VARIANTS ON LUNG INJURY CAUSED BY BACTERIAL PNEUMONIA AND THE EFFECT OF A CHEMICALLY MODIFIED CURCUMIN

Shock (Augusta, Ga.), 2016-04, Vol.45 (4), p.375-384

2016

Volltextzugriff (PDF)

A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras

Molecular carcinogenesis, 2018-09, Vol.57 (9), p.1130-1143

2018

Volltextzugriff (PDF)

Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases

Journal of periodontal research, 2019-10, Vol.54 (5), p.525-532

2019

Volltextzugriff (PDF)

Chemically modified tetracycline-3 (CMT-3): A novel inhibitor of the serine proteinase, elastase

Pharmacological research, 2011-12, Vol.64 (6), p.595-601

2011

Volltextzugriff (PDF)

Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial

Arteriosclerosis, thrombosis, and vascular biology, 2004-04, Vol.24 (4), p.733-738

2004

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(115)

Sprache

Englisch
(115)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(95)
Animals
(71)
Humans
(67)
Male
(47)
Biological And Medical Sciences
(41)
Rats
(39)
Medical Sciences
(37)
Dentistry
(35)
Female
(34)
Tetracyclines - Pharmacology
(33)
Dentistry, Oral Surgery & Medicine
(32)
Biochemistry & Molecular Biology
(24)
Matrix Metalloproteinase Inhibitors
(23)
Pharmacology. Drug Treatments
(20)
Doxycycline - Administration & Dosage
(19)
Middle Aged
(19)
Doxycycline - Pharmacology
(18)
Pharmacology & Pharmacy
(18)
Periodontitis - Drug Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Periodontal therapeutics: Current host‐modulation agents and future directions

Dose‐response assessment of chemically modified curcumin in experimental periodontitis

Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins

pKa, zinc- and serum albumin-binding of curcumin and two novel biologically-active chemically-modified curcumins

Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation

Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases

A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations

Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24

Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation

The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial

A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation

Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non‐antimicrobial tetracycline analog (COL‐3) in a metastatic prostate cancer model

Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study

Introduction and background

Inhibition of Matrix Metalloproteinase‐Mediated Periodontal Bone Loss in Rats: A Comparison of 6 Chemically Modified Tetracyclines

Using tetracyclines to treat osteoporotic/osteopenic bone loss: From the basic science laboratory to the clinic

Periodontal disease in acute coronary syndrome patients

Metalloproteinase Inhibitors, Nonantimicrobial Chemically Modified Tetracyclines, and Ilomastat Block Bacillus anthracis Lethal Factor Activity in Viable Cells

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis

DIFFERENTIAL SUSCEPTIBILITY OF HUMAN SP-B GENETIC VARIANTS ON LUNG INJURY CAUSED BY BACTERIAL PNEUMONIA AND THE EFFECT OF A CHEMICALLY MODIFIED CURCUMIN

A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras

Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases

Chemically modified tetracycline-3 (CMT-3): A novel inhibitor of the serine proteinase, elastase

Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial

Aktive Filter

Suchergebnisse filtern